312 related articles for article (PubMed ID: 23291185)
1. Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.
Ma Y; Ren Y; Han EQ; Li H; Chen D; Jacobs JJ; Gitelis S; O'Keefe RJ; Konttinen YT; Yin G; Li TF
Biochem Biophys Res Commun; 2013 Feb; 431(2):274-9. PubMed ID: 23291185
[TBL] [Abstract][Full Text] [Related]
2. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling in osteosarcoma.
Lin CH; Ji T; Chen CF; Hoang BH
Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
[TBL] [Abstract][Full Text] [Related]
5. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y
Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389
[TBL] [Abstract][Full Text] [Related]
6. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
Liu Y; Wang W; Xu J; Li L; Dong Q; Shi Q; Zuo G; Zhou L; Weng Y; Tang M; He T; Luo J
Oncol Rep; 2013 Oct; 30(4):1723-30. PubMed ID: 23917613
[TBL] [Abstract][Full Text] [Related]
8. Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma.
Cai Y; Mohseny AB; Karperien M; Hogendoorn PC; Zhou G; Cleton-Jansen AM
J Pathol; 2010 Jan; 220(1):24-33. PubMed ID: 19882675
[TBL] [Abstract][Full Text] [Related]
9. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells.
Peng C; Zhang W; Dai C; Li W; Shen X; Yuan Y; Yan L; Zhang W; Yao M
J Ethnopharmacol; 2019 Oct; 243():112092. PubMed ID: 31319122
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells.
Leow PC; Tian Q; Ong ZY; Yang Z; Ee PL
Invest New Drugs; 2010 Dec; 28(6):766-82. PubMed ID: 19730790
[TBL] [Abstract][Full Text] [Related]
11. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
Dieudonné FX; Marion A; Marie PJ; Modrowski D
J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
[TBL] [Abstract][Full Text] [Related]
13. Antitumor Effect of Docetaxel in Osteosarcoma by the Inhibition of Wnt Signal Channel.
Wang DZ; Gao JF; Jing SF; Wei H; Huang XY; Li CD
Drug Res (Stuttg); 2015 Nov; 65(11):597-601. PubMed ID: 25514117
[TBL] [Abstract][Full Text] [Related]
14. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway.
Wu BQ; Cao Y; Bi ZG
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3185-3192. PubMed ID: 28770967
[TBL] [Abstract][Full Text] [Related]
15. SPARCL1 suppresses osteosarcoma metastasis and recruits macrophages by activation of canonical WNT/β-catenin signaling through stabilization of the WNT-receptor complex.
Zhao SJ; Jiang YQ; Xu NW; Li Q; Zhang Q; Wang SY; Li J; Wang YH; Zhang YL; Jiang SH; Wang YJ; Huang YJ; Zhang XX; Tian GA; Zhang CC; Lv YY; Dai M; Liu F; Zhang R; Zhou D; Zhang ZG
Oncogene; 2018 Feb; 37(8):1049-1061. PubMed ID: 29084211
[TBL] [Abstract][Full Text] [Related]
16. Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.
Mödder UI; Oursler MJ; Khosla S; Monroe DG
J Cell Biochem; 2011 May; 112(5):1392-402. PubMed ID: 21321991
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
18. Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma.
Hosseini F; Alemi F; Malakoti F; Mahmoodpoor A; Younesi S; Yousefi B; Asemi Z
Biochem Pharmacol; 2021 Nov; 193():114758. PubMed ID: 34481813
[TBL] [Abstract][Full Text] [Related]
19. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis.
Zhu B; Cheng D; Li S; Zhou S; Yang Q
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455247
[TBL] [Abstract][Full Text] [Related]
20. miR-342-5p inhibits osteosarcoma cell growth, migration, invasion, and sensitivity to Doxorubicin through targeting Wnt7b.
Liu Q; Wang Z; Zhou X; Tang M; Tan W; Sun T; Deng Y
Cell Cycle; 2019 Dec; 18(23):3325-3336. PubMed ID: 31601147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]